CVS expects its overall gross margin to be down significantly in Q4 2013 year to year, on account of a contraction in both the retail and PBM business as well as fewer new generics available to offset continued reimbursement pressure.
CVS expects its overall gross margin to be down significantly in Q4 2013 year to year, on account of a contraction in both the retail and PBM business as well as fewer new generics available to offset continued reimbursement pressure.
Share this Article
Comment on this Article
Recommended
Please to comment